Prolaio builds cardiovascular clinical research infrastructure that turns homes into trial sites using medical-grade wearables to capture continuous real-world heart data. Its intelligence engine translates signals into clinically robust endpoints and FDA-cleared digital biomarkers. Sponsors use the platform for recruitment, 24/7 data capture, adaptive analytics, and dashboards, enabling fully managed real-world trials and post-discharge monitoring. The goal is to make cardiovascular trials faster, scalable, and more accurate by leveraging home data and standardized digital endpoints.
Company Size
51-200
Company Stage
Early VC
Total Funding
$25.5M
Headquarters
Chicago, IL
Founded
2022
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?